US FDA extends review of Merus' gene-targeting cancer therapy
The U.S. Food and Drug Administration on Tuesday extended the review of Merus NV's gene-targeting cancer therapy to allow ...
Food7h
FDA grants more time for Phase II sodium reduction feedback – but is it enough?
FDA is giving the food and beverage industry an additional two months to respond to its request that they slash sodium in ...
What awaits Harris or Trump at the FDA
The FDA faces policy challenges as technological advances roil health care and the agency fights for resources from Congress — no matter who wins the election.
MassDevice1h
FDA clears SimBioSys clinical decision support tech for breast cancer surgery
SimBioSys announced that it received its second FDA 510(k) clearance for TumorSight Viz to expand its use by breast surgeons ...
FierceBiotech9h
FDA delays decision on Merus' first-in-class cancer drug by 3 months
The FDA has scuttled Merus’ plans to win a speedy approval for i | The FDA has scuttled Merus’ plans to win a speedy approval ...
US FDA approves Journey Medical's drug for long-term skin condition
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
STAT1d
A Q&A with the FDA’s top vaccine regulator amid a fresh wave of disinformation
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
Monthly Prescribing Reference1h
FDA Extends Review of Tapinarof Cream for Atopic Dermatitis
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...
People on MSN21h
FDA Recalls Baby Powder Sold in 35 States for Possible Asbestos Contamination
The U.S. Food and Drug Administration (FDA) has issued a recall for Dynacare baby powder, which was sold in 35 states, due to ...
MedPage Today on MSN1d
FDA Approves New Option for Rosacea
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes
Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...
FDA approves Journey Medical's drug for long-term skin condition
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...